Norges Bank’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-695,766
Closed -$24.2M 320
2025
Q4
$24.2M Buy
+695,766
New +$54.6M ﹤0.01% 1201
2025
Q3
Sell
-981,577
Closed -$72M 359
2025
Q2
$72M Buy
981,577
+132,680
+16% +$9.62M 0.01% 816
2025
Q1
$97M Buy
848,897
+14,306
+2% +$871K 0.01% 689
2024
Q4
$42.1M Sell
834,591
-425,387
-34% -$22.3M 0.01% 1027
2024
Q3
$58.3M Buy
1,259,978
+437,855
+53% +$15.6M 0.01% 902
2024
Q2
$26.7M Hold
822,123
﹤0.01% 1139
2024
Q1
$20.7M Buy
822,123
+64,633
+9% +$1.53M ﹤0.01% 1254
2023
Q4
$24.6M Sell
757,490
-95,490
-11% -$2.62M ﹤0.01% 1210
2023
Q3
$23.2M Buy
852,980
+120,000
+16% +$3.47M ﹤0.01% 1170
2023
Q2
$16.3M Buy
732,980
+43,948
+6% +$1.01M ﹤0.01% 1343
2023
Q1
$14.9M Sell
689,032
-81,416
-11% -$1.78M ﹤0.01% 1411
2022
Q4
$15.6M Buy
770,448
+57,221
+8% +$1.43M ﹤0.01% 1385
2022
Q3
$18.3M Buy
713,227
+19,402
+3% +$519K ﹤0.01% 1244
2022
Q2
$16.5M Sell
693,825
-86,897
-11% -$1.89M ﹤0.01% 1329
2022
Q1
$17.6M Sell
780,722
-42,880
-5% -$912K ﹤0.01% 1464
2021
Q4
$16.3M Sell
823,602
-262,800
-24% -$5.33M ﹤0.01% 1571
2021
Q3
$21.4M Buy
1,086,402
+127,727
+13% +$2.67M ﹤0.01% 1443
2021
Q2
$21.1M Buy
958,675
+36,421
+4% +$810K ﹤0.01% 1505
2021
Q1
$21.9M Sell
922,254
-282,244
-23% -$7.54M 0.01% 1493
2020
Q4
$31.5M Sell
1,204,498
-163,214
-12% -$3.44M 0.01% 1283
2020
Q3
$23.8M Sell
1,367,712
-57,684
-4% -$919K 0.01% 1296
2020
Q2
$24M Buy
1,425,396
+369,889
+35% +$5.2M 0.01% 1325
2020
Q1
$12.6M Hold
1,055,507
﹤0.01% 1507
2019
Q4
$12.8M Hold
1,055,507
﹤0.01% 1728
2019
Q3
$14.9M Buy
1,055,507
+182,649
+21% +$2.24M ﹤0.01% 1623
2019
Q2
$9.73M Buy
872,858
+167,533
+24% +$1.87M ﹤0.01% 1807
2019
Q1
$8.28M Hold
705,325
﹤0.01% 1856
2018
Q4
$9.42M Hold
705,325
﹤0.01% 1767
2018
Q3
$9.89M Buy
705,325
+89,300
+14% +$1.25M ﹤0.01% 1821
2018
Q2
$9.68M Buy
616,025
+140,264
+29% +$2.44M ﹤0.01% 1812
2018
Q1
$7.83M Buy
+475,761
New +$8.82M ﹤0.01% 1813

Other funds holding CORT